Business Context and Reporting Period
Company: Glucotrack, Inc. (GCTK)
Filing Type: Form 8-K (Current Report)
Reporting Date: December 29, 2025 (Event Date); December 31, 2025 (Closing Date)
Principal Activity: The Company entered into a Securities Purchase Agreement for a private placement of securities, closing on December 31, 2025. The net proceeds are designated for general corporate purposes.
Key Financial Metrics and Transaction Details
- Gross Proceeds: Approximately $4.0 million.
- Securities Issued:
- 1,033,591 Pre-Funded Warrants (exercisable for 1,033,591 shares of Common Stock).
- Common Warrants to purchase 2,067,182 shares of Common Stock.
- Pricing:
- Pre-Funded Warrant Price: $3.87 per warrant (calculated as the closing price of Common Stock on Dec 29, 2025, minus a $0.001 exercise price).
- Common Warrant Exercise Price: $3.87 per share.
- Placement Agent Compensation:
- Cash Fee: 7.0% of aggregate gross proceeds.
- Warrants: 124,030 Placement Agent Warrants to purchase Common Stock at an exercise price of $4.257 per share.
- Liquidity and Debt: The filing does not provide specific data on existing debt, cash flow, or liquidity positions outside of the proceeds from this transaction.
Material Changes and Agreements
The filing details the entry into several material definitive agreements:
- Securities Purchase Agreement: Governs the private placement. Includes a 60-day lock-up on issuing new equity or filing registration statements (with exceptions for the Registration Rights Agreement) and a 12-month prohibition on Variable Rate Transactions.
- Registration Rights Agreement: Requires the Company to file a registration statement for the resale of securities within 15 calendar days and have it declared effective within 45 days (or 90 days in case of a full SEC review). Includes a penalty provision of 1.5% of the subscription amount per month if the Investor is prohibited from reselling for more than 10 consecutive days or 15 aggregate days in a 12-month period.
- Lock-Up Agreements: Officers and directors are restricted from selling or transferring Common Stock or equivalents for 90 days following the Closing.
- Placement Agency Agreement: Engaged Curvature Securities, LLC as the placement agent.
Guidance, Risks, and Contingencies
- Stockholder Approval Requirement: The Common Warrants (2,067,182 shares) are not exercisable until the Company obtains stockholder approval under Nasdaq rules. They expire five years after the Stockholder Approval Date.
- Ownership Caps:
- Pre-Funded Warrants: Investor cannot exercise if ownership exceeds 9.99% of outstanding shares.
- Common Warrants: Investor cannot exercise if ownership exceeds 4.99% (or 9.99% at the purchaser's election) of outstanding shares.
- Financial Risks: The Company is obligated to pay placement agent commissions and expenses, which will reduce the net proceeds from the $4.0 million gross amount. The filing does not provide specific guidance on future revenue or profitability.
Investor Verification Checklist
- Verify the exact net proceeds after deducting the 7.0% placement agent fee and other transaction expenses.
- Confirm the timeline and status of the required stockholder approval for the Common Warrants.
- Review the Company's current cash position to assess runway given the "general corporate purposes" use of proceeds.
- Monitor the filing of the registration statement required under the Registration Rights Agreement (due within 15 days of the agreement date).
- Check for any subsequent filings regarding the 90-day lock-up expiration for officers and directors.